Description
Highlights in myelodysplastic syndromes and myeloproliferative neoplasms
Article: Highlights in myelodysplastic syndromes and myeloproliferative neoplasms
€2.42
Related products
-
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€2.42 Add to cart -
Article: Highlights in breast cancer
€2.42 Add to cart -
Article: Highlights in squamous cell carcinoma of the head and neck
€2.42 Add to cart -
1 year subscription print edition of the Belgian Journal of Hematology (BJH)
€147.15 Add to cart
Reviews
There are no reviews yet.